D73.1 Hypersplenism

Name of the Condition

• Hypersplenism

Summary

Hypersplenism is a condition characterized by excessive activity of the spleen, leading to the premature destruction of blood cells. The spleen plays a key role in filtering blood, supporting immune responses, and managing red blood cell turnover. In hypersplenism, the spleen becomes overactive, causing anemia, leukopenia, or thrombocytopenia due to accelerated removal of healthy blood cells.

Causes

Causes may include underlying conditions that increase splenic activity, such as chronic liver disease (e.g., cirrhosis), blood disorders (e.g., hemolytic anemia), or infiltrative diseases (e.g., lymphoma). In some cases, splenomegaly (enlarged spleen) due to infection, inflammation, or congestion can contribute to hypersplenism.

Risk Factors

• Chronic liver disease (e.g., cirrhosis)
• Blood disorders (e.g., hemolytic anemia, thalassemia)
• Infiltrative diseases (e.g., lymphoma, amyloidosis)
• Infections (e.g., malaria, mononucleosis)
• Congestive splenomegaly (e.g., portal hypertension)
• Autoimmune conditions

Symptoms

• Fatigue or weakness (due to anemia)
• Easy bruising or bleeding (due to thrombocytopenia)
• Increased susceptibility to infections (due to leukopenia)
• Abdominal fullness or pain (from splenomegaly)
• Pale skin or jaundice (in severe cases)

Diagnosis

Diagnosis typically involves clinical evaluation, blood tests to assess cell counts, and imaging (e.g., ultrasound, CT) to evaluate spleen size. Additional tests may include bone marrow biopsy to rule out primary hematologic disorders. Clinical correlation with underlying conditions is essential.

Treatment Options

Treatment focuses on addressing the underlying cause. Options may include managing liver disease, treating infections, or addressing blood disorders. In severe cases, splenectomy (surgical removal of the spleen) or partial splenic embolization may be considered to reduce splenic activity.

Prognosis and Follow-Up

Prognosis depends on the underlying condition and response to treatment. Regular monitoring of blood cell counts and spleen size is important. Patients may require long-term follow-up to manage complications, such as infection risk or anemia.

Complications

• Severe anemia or thrombocytopenia
• Increased risk of infections
• Splenic rupture (rare, due to enlargement)
• Worsening of underlying conditions (e.g., liver failure)

Lifestyle & Prevention

• Manage underlying conditions (e.g., liver disease, infections)
• Avoid activities that increase injury risk (e.g., contact sports, if splenomegaly is present)
• Follow vaccination recommendations (e.g., pneumococcal vaccine) to reduce infection risk
• Maintain a balanced diet to support overall health

When to Seek Professional Help

Seek medical attention if you experience unexplained fatigue, bruising, frequent infections, or abdominal pain. Prompt evaluation is important if symptoms worsen or new symptoms develop, as hypersplenism may indicate an underlying condition requiring treatment.

Tips for Medical Coders

Document the underlying cause (e.g., cirrhosis, hemolytic anemia) when coding for hypersplenism, as it often accompanies other conditions. Ensure clinical correlation between splenic activity and blood cell destruction is clear. Code D73.1 is specific to hypersplenism; avoid using it for general splenic disorders without supporting documentation.